Sign up to save your podcasts
Or
Share Kymera Therapeutics' Founder & CEO Nello Mainolfi recaps Monday's STAT6 data and discusses the next steps in development
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Kymera Therapeutics' Founder & CEO Nello Mainolfi recaps Monday's STAT6 data and discusses the next steps in development
He talks about Kymera's dosing methodology, and recaps the data from a degredation, biomarker, and clinical outcomes standpoint. Plus, next steps in STAT6, and thoughts on the platform in general and the field more broadly.
View all episodes
By BiotechTV
4.3
66 ratings
He talks about Kymera's dosing methodology, and recaps the data from a degredation, biomarker, and clinical outcomes standpoint. Plus, next steps in STAT6, and thoughts on the platform in general and the field more broadly.
More shows like BiotechTV - News
View all
We Study Billionaires - The Investor’s Podcast Network
3,365 Listeners
Bloomberg Businessweek
413 Listeners
WSJ Tech News Briefing
1,645 Listeners
The Meb Faber Show - Better Investing
949 Listeners
The Long Run with Luke Timmerman
123 Listeners
The Readout Loud
321 Listeners
Value Investing with Legends
211 Listeners
Fiction - Comedy Fiction
6,444 Listeners
Biotech 2050 Podcast
62 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,997 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
33 Listeners
Biotech Hangout
20 Listeners
The Studio at Kendall Square
0 Listeners
Off-Target Effects with Matt Gline
4 Listeners
Biotech CEO Sisterhood
2 Listeners
BioVenture VoiCes with Chris Garabedian
5 Listeners
Cheeky Pint
37 Listeners